Skip to main content

Sources last read

The list

Is semaglutide or tirzepatide in shortage?

Neither semaglutide nor tirzepatide is on FDA’s shortage list today, checked 14 August 2026. Nothing on this page is a stock check: it is what one federal database held on one morning.

Source: FDA’s drug shortage database, read 2026-08-14

What matters first

Molecules checked
2
Currently in shortage
0
Database rows
3
What this is not
A local pharmacy stock check

This matters beyond supply. A drug on FDA’s shortage list counts as not commercially available, and that is the switch that lets a pharmacy mix a copy of it. The rules that switch turns on are the subject of their own page. This one is the list.

Where each drug stands

One row per drug, read on 14 August 2026. The three record types are counted in their own columns, because adding them together is the mistake this whole page is built to avoid.

What FDA’s shortage database holds for each drug, split by record type
DrugIn shortageRecordsCurrent shortageSupply-ending noticeClosed shortageChecked
SemaglutideNot in shortage30302026-08-14
TirzepatideNot in shortage00002026-08-14

Semaglutide

Semaglutide is not on FDA’s shortage list, checked 14 August 2026.

Tirzepatide

Tirzepatide is not on FDA’s shortage list, checked 14 August 2026.

A discontinuation is not a shortage

FDA files three different things in one database, told apart only by a status word. Count the rows and you get a number that means nothing. Read the word and you get the answer.

  • Current. FDA lists this as a current shortage.
  • To be discontinued. A manufacturer has told FDA it is stopping this product. A discontinuation is not a shortage.
  • Resolved. A shortage FDA has since closed.

The trap is worse than it sounds, because the database also matches on its own free text. Ask it about Ozempic without naming a field and it hands back three Rybelsus rows, matched on a sentence saying Rybelsus will be replaced by Ozempic. Every query behind this page names the field it searches, and every returned row is checked back against the names the query expected.

Every record behind those answers

3 rows came back in total. Here they are, so nothing above rests on a count you cannot check. A drug missing from this table is a drug with no record at all.

Each record FDA’s shortage database returned, with its status word verbatim
DrugFDA statusProduct as FDA writes itCompanyPostedUpdated
SemaglutideTo Be DiscontinuedRybelsus, Tablet, 14 mg (NDC 0169-4314-30)Novo Nordisk, Inc.4 June 20264 June 2026
SemaglutideTo Be DiscontinuedRybelsus, Tablet, 3 mg (NDC 0169-4303-30)Novo Nordisk, Inc.4 June 20264 June 2026
SemaglutideTo Be DiscontinuedRybelsus, Tablet, 7 mg (NDC 0169-4307-30)Novo Nordisk, Inc.4 June 20264 June 2026

How the shortage tracker stays current

A script asks openFDA about each drug and writes the answer into this repository, dated. A person reviews the change before it ships. The status is pulled from FDA data rather than typed by hand, and the displayed date shows when it was last checked.

The query behind every row is stored with it and travels inside both downloads. Paste one into the endpoint below and you get the same rows back, which is the only kind of sourcing that settles an argument.

Status comes from FDA’s drug shortage database on the date shown. The list changes daily. Retrieved 2026-08-14 from https://api.fda.gov/drug/shortages.json · openFDA data last updated 2026-08-14

How everything on this site is sourced →

What this list does not tell you

  • Manufacturers report shortages to FDA under 21 U.S.C. 356C. A drug missing from the database is a drug nobody has reported as in shortage — not a promise that a pharmacy has it.
  • A discontinuation notice is not a shortage. FDA files both in the same database under different statuses.
  • Shortage listing switches off the rule against compounding a copy of an available drug. It does not by itself make any compounded preparation lawful.
  • This is a dated snapshot of a daily feed, not a live lookup.
  • Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.

Questions people actually ask

Is semaglutide in shortage right now?

Semaglutide is not on FDA’s shortage list, checked 14 August 2026. The list moves daily, so read the date beside that sentence rather than the sentence alone.

Why does the database hold semaglutide rows if there is no shortage?

Because a notice that a company is stopping a product lives in the same database. Novo Nordisk told FDA it is retiring Rybelsus tablets, which are being replaced by an Ozempic tablet. That is a business decision, not a supply failure, and the two are only told apart by the status word on the row.

Does a shortage listing make compounded semaglutide legal?

No. It removes one specific bar — the rule against compounding a copy of a commercially available drug. Every other condition in sections 503A and 503B still applies, and those are covered separately.

Does an empty list mean my pharmacy has the drug?

No. Manufacturers report shortages to FDA under 21 U.S.C. 356C, so an absent drug is a drug nobody has reported. Whether a particular pharmacy has stock today is a question for that pharmacy.

How often is this checked?

Every time the feed is re-read, which is what dates this page. 0 of 2 tracked drugs were listed on 14 August 2026.

Take the list

One row per drug, including a drug FDA holds no record for at all. Each row carries the day it was read, because a row pasted out of the file loses the header that would otherwise date it.

The three record types stay in three columns. Nothing in the file adds them up, and neither should anything built on it.

How to cite this table

HealthspanLedger. FDA shortage status for GLP-1 drugs. Edition 2026.08 (version c8b4cf25d815). Derived from openFDA drug shortage database, US Food and Drug Administration, retrieved 2026-08-14. Licensed CC BY 4.0. https://healthspanledger.com/compounded/shortages

Analysis by HealthspanLedger · edition 2026.08 · version c8b4cf25d815 · retrieved 2026-08-14

The underlying records are us government work, public domain and carry no copyright: the publisher’s own license. This table — how we select, join, label and bound the facts — is ours, and it is published under Creative Commons Attribution 4.0 International (CC BY 4.0). Reuse it, including commercially, and credit HealthspanLedger with a link to this page.

Sources

  1. openFDA drug shortage database — the endpoint behind every row on this page · US Food and Drug Administration · retrieved 2026-08-14
  2. FDA drug shortage database — the public search page, for checking us · US Food and Drug Administration · retrieved 2026-08-14
  3. openFDA data license — US Government work, public domain · US Food and Drug Administration · retrieved 2026-08-14